Loading...
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
INTRODUCTION: Hereditary proximal spinal muscular atrophy (SMA) is caused by homozygous loss of function of the survival motor neuron 1 gene. The main characteristic of SMA is degeneration of alpha motor neurons in the anterior horn of the spinal cord, but recent studies in animal models and patient...
Na minha lista:
| Udgivet i: | BMJ Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6067401/ https://ncbi.nlm.nih.gov/pubmed/30061431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-019932 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|